Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
93,342,407
-
Share change
-
-4,370,692
-
Total reported value
-
$8,012,433,007
-
Put/Call ratio
-
90%
-
Price per share
-
$85.84
-
Number of holders
-
421
-
Value change
-
-$352,899,046
-
Number of buys
-
153
-
Number of sells
-
223
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2014
As of 30 Jun 2014,
Edwards Lifesciences Corp - Common Stock (EW) was held by
421 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,342,407 shares.
The largest 10 holders included
Capital World Investors, Capital Research Global Investors, VANGUARD GROUP INC, FMR LLC, WELLINGTON MANAGEMENT CO LLP, State Street Corp, GENERATION INVESTMENT MANAGEMENT LLP, BlackRock Institutional Trust Company, N.A., Fairpointe Capital LLC, and BlackRock Fund Advisors.
This page lists
421
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.